Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript March 1, 2024
Biodesix, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.11.
BDSX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good day and thank you for standing by. Welcome to the Biodesix’s Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions]. Please be advised that today’s conference is being recorded....
